The transcription factor ThPOK is required and sufficient for the generation of CD4 + CD8thymocytes, yet the mechanism by which ThPOK orchestrates differentiation into the CD4 + helper T cell lineage remains unclear. Here we used reporter mice to track the expression of transcription factors in developing thymocytes. Distal promoter-driven expression of the gene encoding the transcription factor Runx3 was restricted to major histocompatibility complex (MHC) class I-selected thymocytes. In ThPOK-deficient mice, such expression was derepressed in MHC class II-selected thymocytes, which contributed to their redirection to the CD8 + T cell lineage. In the absence of both ThPOK and Runx, redirection was prevented and cells potentially belonging to the CD4 + lineage, presumably specified independently of ThPOK, were generated. Our results suggest that MHC class II-selected thymocytes are directed toward the CD4 + lineage independently of ThPOK but require ThPOK to prevent Runx-dependent differentiation toward the CD8 + lineage.
The development of ab T cells requires rearrangement of the loci encoding T cell antigen receptor-a (TCRa) and TCRb and appropriate signals transduced through interactions between TCRs on CD4 + CD8 + double-positive (DP) thymocytes and peptide in the context of major histocompatibility complex (MHC) molecules on thymic stromal cells. Only a small proportion of DP thymocytes are selected for differentiation into mature cells that home to peripheral secondary lymphoid organs. This positive selection process is accompanied or followed by coordinated activation and/or repression of genes that 'program' differentiation of the selected thymocytes into specific lineages of mature T cells. CD4 + helper T cells and CD8 + cytotoxic T cells constitute most of the mature ab T lymphocytes in mice and humans. After positive selection, DP cells expressing MHC class I-or MHC class II-restricted TCRs undergo differentiation into T cells of the CD8 + and CD4 + lineage, respectively; this differentiation involves transcriptional downregulation of one or the other coreceptor 1 . CD4 expression is terminated in CD4 -CD8 + single-positive (CD8 SP) thymocytes through activation of the Cd4 silencer, a negative cis-regulatory element in the Cd4 locus; Cd4 silencing is subsequently maintained by epigenetic mechanisms 2, 3 . CD8 expression is transiently downregulated in both MHC class I-and MHC class II-restricted thymocytes and is selectively reactivated in MHC class I-restricted CD8 SP cells through stage-specific enhancers 4 . In addition to Cd4, Cd8a and Cd8b, other genes are selectively activated or repressed in each mature T cell lineage, and a principal goal in this field has been to elucidate how lineage-specific gene regulation is coordinated.
During early hematopoiesis, a balance among distinct lineagespecific transcription factors determines the fate of mature cells derived from common multipotent progenitors 5 . Similar generegulatory networks may regulate the CD4-versus-CD8 lineage 'decision' . The C2H2-type zinc-finger transcription factor ThPOK is necessary and sufficient for the generation of CD4 SP thymocytes after positive selection 6, 7 . Helper-deficient (hd/hd) mice, which have a mutation in the gene encoding ThPOK (Zbtb7b; called 'ThPOK' here), lack CD4 + helper T cells, and thymocytes selected by MHC class II are redirected to the CD8 + T cell lineage. Forced expression of ThPOK results in redirection of MHC class I-restricted thymocytes to the CD4 + T cell lineage 6, 7 .
Whereas ThPOK exerts a dominant influence over the differentiation of CD4 SP thymocytes, it is not clear if differentiation of CD8 SP thymocytes requires such a pivotal factor or occurs by default if ThPOK is not upregulated. The Runx family of transcriptional regulators have been identified as being crucial to the Cd4 silencing associated with differentiation of the CD8 + cytotoxic T cell lineage 8 . Among the three Runx proteins that form heterodimers with the common subunit CBFb (A000524), Runx3 is the chief mediator of heritable Cd4 silencing during development of the CD8 SP lineage, and Runx1 (A000523) also contributes to partial Cd4 silencing in the absence of Runx3 (refs. 8, 9) . Conditional inactivation of both Runx1 and Runx3 at the DP stage of thymocyte differentiation results in a complete loss of CD8 SP thymocytes, although CD4 SP thymocytes are still generated 10 . Runx3 protein is detected in CD8 SP thymocytes but not CD4 SP thymocytes, even though Runx3 mRNA is upregulated in both lineages after positive selection 10, 11 . Such findings suggest that Runx3 expression is regulated at least in part through post-transcriptional mechanisms. Runx transcripts are initiated at two distinct sites: expression of Runx3 from the distal promoter is detected exclusively in CD8 SP thymocytes, whereas CD4 SP cells express only the proximal promoter-derived transcript that is not sufficient for protein synthesis 10 . Those results, together with the finding that Runx1 inactivation alone exerts little influence on development of the CD8 + lineage 10 , suggest that the CD8 + lineage-specific requirement for Runx function is satisfied mainly by Runx3 (ref. 10) and that activation of the Runx3 distal promoter (called 'Runx3d' here) is a key event required for the CD8 + lineage differentiation of MHC class Irestricted thymocytes. Even though it is not expressed in naive peripheral CD4 + T cells, Runx3 protein is upregulated in T helper type 1 (T H 1) cells that produce interferon-g (IFN-g), where it contributes to repression of the gene encoding interleukin 4 (IL-4), but the mechanism for its regulation in these cells is not known 12, 13 .
ThPOK expression in developing thymocytes is regulated by a cis-acting silencer element that is needed to restrict ThPOK expression to the CD4 + lineage 14, 15 . In the absence of this silencer, ThPOK is prematurely expressed in DP thymocytes, and all positively selected thymocytes differentiate into cells of the CD4 + lineage 14 . The ThPOK silencer is bound by Runx complexes, and ThPOK is prematurely expressed in preselection DP thymocytes in the absence of both Runx1 and Runx3 (ref. 14) . That finding suggests that ThPOK activity is required for diversion of MHC class I-selected Runx-deficient thymocytes to the helper T cell lineage and suggests that Runx proteins continue to suppress ThPOK expression after positive selection of MHC class I-restricted thymocytes. However, a requirement for Runx complexes in lineage-specific silencing of ThPOK has been disputed 14, 15 .
To clarify the gene-regulatory network that governs the lineage determination of ab T cells, we generated 'knock-in' reporter strains that facilitate single-cell analysis of ThPOK and Runx3d expression in MHC class I-and MHC class II-selected thymocytes. By analyzing these reporter mice, we found that ThPOK prevented upregulation of Runx3 and other CD8 lineage-specific genes. We obtained genetic evidence suggesting that ThPOK stabilizes the fate of MHC class II-selected thymocytes that would otherwise be diverted to the CD8 SP lineage because of constitutive Runx function. We also found that ThPOK was not required for the appearance of CD4 SP cells in an environment in which MHC class II-specific thymocytes were positively selected; this last finding suggests that other factors act 'upstream' of ThPOK to direct CD4 expression after positive selection.
RESULTS
Runx3d is required for Runx3 protein expression in CD8 + T cells To visualize thymocytes expressing Runx3d mRNA, we generated a reporter allele (Runx3d YFP ) by replacing the first coding exon used by the Runx3 distal promoter with sequence encoding yellow fluorescent protein (YFP; Supplementary Fig. 1a online). In accordance with published analyses of Runx protein and mRNA expression 10 , we detected YFP expression in CD8 + T cells but not in CD4 + T cells or B220 + cells among peripheral blood lymphocytes from mice heterozygous for this allele (Runx3d YFP/+ mice; Supplementary Fig. 1b ). To determine whether Runx3 distal promoter activity is required for Runx3 protein expression in CD8 + T cells, we generated homozygous Runx3d YFP/YFP mice in which distal promoter-derived Runx3 expression was eliminated. Whereas germline deletion of both proximal promoter-derived and distal promoter-derived Runx3 results in neonatal death on the 129 or C57BL/6 genetic background 16, 17 , Runx3d YFP/YFP mice were viable and fertile and had no gross abnormalities (data not shown). Runx3 protein was almost undetectable in CD8 + T cells and was much lower in T H 1-polarized activated CD4 + T cells from Runx3d YFP/YFP mice than in those from Runx3d YFP/+ mice ( Fig. 1a and Supplementary Fig. 1c,d ). Runx1 was upregulated in Runx3-deficient CD8 + T cells from both Cd4-Cre + Runx3 F/F mice (positive for Cre recombinase under regulation of Cd4 control elements and homozygous for loxP-flanked Runx3) and Runx3d YFP/YFP mice ( Fig. 1a and Supplementary Fig. 1d ). This result indicates that most Runx3 protein is derived from the distal promoter-driven transcript both in CD8 + T cells and T H 1-polarized CD4 + T cells and that only a small amount of Runx3 protein is expressed from the proximal promoter in T cells. In CD8 + T cells from Runx3d YFP/YFP mice, Cd4 silencing was incomplete and there was no upregulation of the expression of CD103 (integrin a E ), which has been shown to be dependent on Runx3 (ref. 18 ; Fig. 1b ,c). Thus, Runx3 expression from the distal promoter is required for Cd4 silencing and CD103 expression in CD8 SP thymocytes.
To investigate the regulation of Runx3d expression in developing thymocytes, we next examined YFP expression in a series of intermediate thymocyte subsets defined by their expression of CD4, CD8, TCRb, CD69 and CD24 (heat-stable antigen (HSA); Fig. 2a and Supplementary Fig. 2a ,b online). We did not detect YFP + cells among preselected CD69 -DP thymocytes (data not shown). After positive selection, MHC class I-and MHC class II-selected thymocytes both transit through an intermediate CD69 + HSA hi TCRb int CD4 + CD8 lo stage [19] [20] [21] [22] [23] [24] [25] (called 'CD4 + CD8 lo ' here; Supplementary Fig. 2c ). At this stage, we noted 2-5% of cells expressed YFP ( Fig. 2a and Supplementary Fig. 2d ). These YFP + cells were absent from Runx3d YFP/+ mice on a background deficient in b 2 -microglobulin (B2m -/-), an essential component of MHC class I molecules ( Supplementary  Fig. 2d ). This indicated that Runx3d transcription is activated only in positively selected MHC class I-restricted thymocytes. After the CD4 + CD8 lo stage, MHC class I-selected thymocytes become CD4 + CD8 + CD69 + TCRb hi ; such cells were absent from B2m -/mice ( Supplementary Fig. 2e ). In contrast, MHC class II-restricted thymocytes continue to downregulate surface CD8 expression to become CD4 + CD8thymocytes before downregulating HSA. Most CD4 + CD8 + CD69 + TCRb hi thymocytes expressed YFP, and cells with the highest surface TCRb expression were brightest for YFP ( Fig. 2a) .
Mature HSA lo-neg CD8 SP thymocytes had uniformly high expression of YFP ( Fig. 2a ). We did not detect YFP expression in the MHC class II-restricted CD4 + CD8 -HSA hi population. These results indicated that Runx3d YFP expression was highly restricted to MHC class Iselected thymocytes, that it occurred mainly after the transit from the CD4 + CD8 lo stage and that it specifically marked developing CD8 SP thymocytes.
ThPOK expression in developing thymocytes
To visualize ThPOK expression in individual differentiating thymocytes, we generated a green fluorescent protein (GFP)-expressing 'knock-in' allele of ThPOK by replacing all of exons 2 and 3 with cDNA encoding GFP (ThPOK GFP ; Supplementary Fig. 3a online) . In the periphery, all CD4 + T cells had high expression of GFP, and a small proportion of CD8 + T cells expressed GFP, although at approximately one tenth the quantity in CD4 + T cells ( Supplementary Fig. 4a online) 6, 7 . A large proportion of B220 + cells also had low expression of GFP ( Supplementary Fig. 4a ). In the thymus, we did not detect GFP + cells among CD69preselected DP thymocytes (data not shown).
After positive selection, approximately half of the CD4 + CD8 lo cells and all mature CD4 SP thymocytes had high expression of GFP ( Fig. 2b) . On the B2m -/background, a larger proportion of the CD4 + CD8 lo thymocytes expressed GFP because of enrichment for MHC class II-restricted cells ( Fig. 2c) . At the CD4 + CD8 lo stage, we noted distinct GFP hi and GFP lo populations ( Fig. 2b) . GFP hi cells had slightly higher TCRb expression ( Fig. 2b) , which suggested that MHC class II-selected thymocytes undergo maturation while upregulating ThPOK during the CD4 + CD8 lo stage. Thus, expression of ThPOK occurs earlier in differentiation than does expression of Runx3d. Consistent with the low GFP expression in peripheral CD8 + T cells, only a small subset of MHC class I-selected thymocytes had low expression of GFP. In ThPOK GFP/+ H2-Ab1 -/mice, which lack MHC class II (H2-A b ) molecules, approximately 5% of the CD4 + CD8 lo , CD4 + CD8 + CD69 + TCRb hi and CD4 lo-neg CD8 + populations had low expression of GFP ( Fig. 2c and data not shown). Approximately 4% of CD4 + CD8 + CD69 + TCRb hi and CD4 lo-neg CD8 + thymocytes coexpressed Runx3d YFP and small amounts of ThPOK GFP (Fig. 2d ), but we did not detect cells with high expression of both reporters. Thus, high expression of ThPOK and Runx3d in positively selected thymocytes may be mutually exclusive.
We also generated mice with a null allele for ThPOK (Supplementary Fig. 3b ) and examined ThPOK GFP/mice expressing no ThPOK protein. ThPOK GFP/mice had very few mature HSA lo-neg CD4 SP cells, but the total number of TCR hi HSA lo-neg thymocytes remained normal ( Supplementary Fig. 4b ). This phenotype was similar to that of helper-deficient (hd/hd) mice 26 . As GFP expression in the CD69 + HSA hi CD4 + CD8 lo-neg subpopulation was similar for ThPOK GFP/+ mice and ThPOK GFP/mice, ThPOK upregulation during positive selection seemed unlikely to be dependent on ThPOK expression itself (discussed below). We noted substantial GFP expression in approximately two thirds of CD8 SP thymocytes and peripheral CD8 + T cells from ThPOK GFP/mice ( Fig. 2e ). GFP expression in CD8 + GFP + T cells in the periphery was approximately 30% of that in CD4 + T cells (data not shown). All CD8 SP thymocytes from ThPOK GFP/-B2m -/mice expressed GFP ( Supplementary Fig. 4c ), which indicated that they were MHC class II-restricted cells redirected from the CD4 SP lineage. These findings suggest that MHC class II-restricted positive selection is required and sufficient to turn on high ThPOK expression.
ThPOK blocks Runx3 expression
To determine whether there was cross-regulation of ThPOK and Runx3 during thymocyte lineage specification, we examined expression of the ThPOK and Runx3d reporters in the absence of one or the other factor. ThPOK GFP expression was unaffected by disruption of RunX3d or by transgenic overexpression of Runx3 (data not shown). In contrast, Runx3d YFP was ectopically expressed in MHC class II-restricted thymocytes from ThPOK-deficient mice (Fig. 3a) , which suggested that ThPOK acts as an 'upstream' negative regulator of Runx3 expression. Approximately 30-40% of CD4 + CD8 -HSA hi thymocytes expressed Runx3d YFP in the absence of ThPOK; these YFP + cells had the highest expression of TCRb ( Fig. 3a) . ThPOK GFP was upregulated despite the absence of ThPOK protein in MHC class II-restricted CD4 + CD8 -HSA hi thymocytes, which were present only in MHC class II-sufficient mice and were eventually redirected to the CD8 SP lineage (Fig. 3b,c) . These findings suggest that Runx3d YFP derepression is an early indication of the lineage redirection of ThPOK-deficient 'CD4 SP-wannabe' cells to the CD8 + T cell lineage.
Lineage redirection due to a hypomorphic ThPOK allele Our data indicated that ThPOK expression after MHC class IIrestricted positive selection prevented expression of Runx3d. However, our analysis of ThPOK GFP expression showed that a small proportion of CD8 + T cells also expressed ThPOK but differentiated into the cytotoxic lineage with normal Runx3d YFP expression. That observation suggested there is a threshold of ThPOK expression that is required for helper T cell lineage commitment. To study the effect of lower ThPOK quantities, we used a hypomorphic ThPOK allele in which the phosphoglycerate kinase-neomycin-resistance selection cassette remained in intron 1 of the ThPOK locus (ThPOK FN ; Supplementary  Fig. 3 ). CD4 + CD8mature thymocytes and peripheral T cells were still present in ThPOK FN/mice even though ThPOK expression was 80% lower than that of control CD4 + T cells, as determined by quantitative RT-PCR, by ThPOK protein expression and by GFP expression from a 'ThPOK GFP-neo ' allele (the ThPOK GFP allele with the phosphoglycerate kinase-neomycin-resistance cassette in the same context as in the ThPOK FN allele; Fig. 4a,b and Supplementary Fig. 3 ). ThPOK FN/mice had fewer CD4 + CD8cells and more CD4 -CD8 + cells than did ThPOK +/+ , ThPOK FN/+ , ThPOK +/or ThPOK FN/FN mice among HSA lo-neg mature thymocyte and peripheral T cell populations, which resulted in an inverted ratio of CD4 + cells to CD8 + cells (Fig. 4c ). CD4 -CD8 + mature thymocytes and peripheral T cells, as well as CD4 SP cells, were present in ThPOK FN/-B2m -/mice ( Fig. 4c) , which indicated that some MHC class II-selected cells were redirected to the CD8 SP lineage in the presence of attenuated ThPOK. In addition to cells expressing CD4 or CD8, we noted atypical populations of mature thymocytes and T cells with a CD4 + CD8 + phenotype in ThPOK FN/and ThPOK FN/-B2m -/mice ( Fig. 4c) , which suggested that the presence of lower quantities of ThPOK during thymocyte development affected the CD4-versus-CD8 lineage 'decision' . These DP cells and a fraction of CD4 -CD8 + T cells expressed GFP in ThPOK FN/GFP mice, consistent with their being MHC class II restricted ( Supplementary Fig. 5a online) . These results suggest that during CD4 SP thymocyte development, a threshold amount of ThPOK expression is needed to mediate CD4 SP thymocyte differentiation and that when ThPOK falls below this threshold, MHC class II-restricted cells are diverted to a CD8 + lineage fate. Unstimulated peripheral CD4 + T cells do not normally express Runx3 protein. However, we found that peripheral CD4 + CD8 -T cells from ThPOK FN/mice constitutively expressed Runx3 and CD4 + CD8 -T cells from ThPOK FN/-Runx3d YFP/+ mice expressed YFP ( Fig. 4d and Supplementary Fig. 5b online) . Runx3 protein expression was higher in CD4 + CD8 + cells, and GFP expression from the ThPOK GFP-neo allele, which reflects ThPOK mRNA expression from the ThPOK FN allele, was inversely correlated with Runx3 protein expression ( Fig. 4d and Supplementary Fig. 5 ). These results indicate that a large amount of ThPOK is needed to block Runx3 upregulation and diversion of MHC class II-restricted thymocytes to the CD8 SP lineage.
Generation of CD4 SP cells in the absence of ThPOK
Our data indicated a correlation between Runx3 derepression and redirection of MHC class II-restricted thymocytes to the cytotoxic lineage. To determine whether Runx complexes were required for lineage redirection occurring in the absence of ThPOK, we generated mice doubly deficient in ThPOK and CBFb. We used the Lck-Cre transgene to conditionally inactivate Cbfb because later inactivation of Cbfb in DP thymocytes with Cd4-Cre allows the generation of CD8 + mature thymocytes (which derepress Cd4) 12 , most likely because of the long half-life of CBFb protein. Conditional inactivation of Cbfb with Lck-Cre allows thymocytes to proceed through b-selection and represents a 'phenocopy' of the loss of both Runx1 and Runx3 at the DP stage. The numbers of HSA hi CD69 + and HSA hi TCRb hi positively selected thymocytes in Lck-Cre + Cbfb F/F mice and Lck-Cre + Cbfb F/F ThPOK GFP/mice were approximately 20% of those in littermate control or ThPOK-deficient mice (Fig. 5 ). Similar to published results obtained with Cd4-Cre + Runx1 F/F Runx3 F/F mice 10 , CD4 -CD8 + mature thymocytes with intact Cd4 silencing, which had escaped Cre-mediated inactivation of Cbfb, were present in Lck-Cre + Cbfb F/F mice. Although almost all of the mature thymocytes were redirected to the CD8 SP subset in Lck-Cre + Cbfb +/+ ThPOK GFP/mice, most of the mature HSA lo thymocytes in Lck-Cre + Cbfb F/F ThPOK GFP/mice were CD4 + CD8and were not redirected to the CD8 lineage ( Fig. 5a) . We also noted a CD4 + CD8 -T cell population not redirected to the CD8 lineage in lymph nodes of Lck-Cre + Cbfb F/F ThPOK GFP/mice (Fig. 5a) . The numbers of CD4 + CD8thymocytes and peripheral T cells in Lck-Cre + Cbfb F/F ThPOK GFP/mice were lower than those in wild-type mice but were similar to the numbers in Lck- ( Fig. 5b) . We do not believe that these cells represented a rare population of unconventional CD4 SP thymocytes, as invariant natural killer T cells do not develop in the absence of Runx complexes 27 and regulatory T cells expressing the transcription factor Foxp3 are much fewer in number in both CBFb-deficient mice and ThPOK-deficient mice (unpublished data). In addition, CD40L (CD154) was expressed in CD4 + T cells lacking both transcription factors, consistent with their being helper-lineage cells (Supplementary Fig. 6 online) . Thus, these findings indicate that Runx complexes are required for redirection of MHC class II-restricted thymocytes toward the CD8 SP lineage in the absence of ThPOK and that ThPOK is not required for CD4 expression in mature MHC class II-restricted thymocytes and CD4 + peripheral T cells.
ThPOK represses genes specific for the CD8 SP lineage
The finding of Runx3d derepression in ThPOK-deficient MHC class II-restricted thymocytes raised the possibility that other CD8 + lineage-specific genes might also be derepressed in such cells. To assess that possibility, we compared the gene expression of CD4 + CD8 -HSA hi GFP + thymocytes from ThPOK GFP/and ThPOK GFP/+ mice. Quantitative RT-PCR analysis showed that ThPOK GFP/cells had significantly higher expression of transcripts normally expressed in the CD8 SP lineage of wild-type mice, including Cd8a, Itgae, Nkg7, Cd160 and Prf1 (Fig. 6a) . In addition, unlike wild-type CD4 + T cells, most ThPOK FN/-CD4 + T cells produced IFN-g when stimulated with antibody to CD3 (anti-CD3) and anti-CD28 in the absence IL-12 (Fig. 6b) . Expression of the CD8 + lineage-specific, IFN-g-regulating transcription factor Eomes was significantly higher in ThPOK FN/than in wild-type CD4 + T cells (Fig. 6c) . These findings suggest that a large amount of ThPOK expression is required during the development of CD4 + T cells to block the CD8 SP lineage-specific gene-expression program.
DISCUSSION
Despite extensive effort over the past two decades, the mechanism by which DP cells undergoing positive selection commit to either the CD4 + or CD8 + lineage is not yet understood. The discovery of the hd mouse, which has a mutation in the gene that encodes ThPOK, showed that positive selection could occur independently of lineage commitment 26, 28 . Subsequent studies have suggested that ThPOK serves as a 'master regulator' that directs the differentiation of helper T cells 6, 7 . That conclusion was based on the findings that forced expression of ThPOK redirects MHC class I-selected thymocytes to the CD4 + lineage and that MHC class II-selected cells adopt the CD8 + lineage fate in the absence of functional ThPOK. Furthermore, a defect in a Runx-dependent silencer in ThPOK results in derepression of ThPOK in DP cells and in redirection of MHC class I-selected thymocytes 14 . Here we have shown that ThPOK was upregulated in positively selected CD4 + CD8 lo thymocytes before induction of Runx3 in cells destined to become CD8 + T cells, that ThPOK repressed expression of Runx3 in MHC class II-selected cells transiting from the CD4 + CD8 lo to the CD4 + CD8stage and, notably, that MHC class II-selected thymocytes could become CD4 SP cells even in the absence of ThPOK and thus may be specified to the helper lineage independently of ThPOK. These results suggest that ThPOK may not be a 'master regulator' but instead that it reinforces the CD4 + lineage 'decision' , at least in part by repressing Runx3 and thus preventing cells from expressing CD8 + lineagespecific genes.
Among the three Runx proteins, Runx3 is the only one specifically expressed in the CD8 + lineage, where the gene is transcribed from its distal promoter. Conditional inactivation of Runx3 results in derepression of Cd4 in T cells of the CD8 + lineage but not in loss of CD8 SP thymocytes or in redirection of MHC class I-restricted thymocytes to the CD4 SP lineage 10 . This is most likely explained by functional redundancy achieved after compensatory upregulation of Runx1, and, accordingly inactivation of both Runx1 and Runx3 in DP thymocytes results in complete loss of cells of the CD8 + lineage and in lineage redirection 10, 14 . Such results thus suggest that in the absence of genetic manipulation, activation of the Runx3 distal promoter is critical for the initiation of CD8 SP development. Here we have shown that ThPOK suppressed Runx3d expression in MHC class II-selected cells. After positive selection, a large proportion of MHC class II-restricted thymocytes in the CD4 + CD8 lo population expressed the ThPOK GFP reporter, but the Runx3d YFP reporter was not expressed by MHC class I-restricted thymocytes until they differentiated further. ThPOKdeficient MHC class II-restricted thymocytes, in contrast, derepressed Runx3d after they upregulated ThPOK GFP reporter expression in CD4 + CD8 lo-neg subsets. That observation suggests that CD4 + T cell differentiation requires high ThPOK expression that is initiated before Runx3 upregulation. In the presence of insufficient amounts of ThPOK, MHC class II-restricted thymocytes fail to block Runx3 expression and are redirected to the CD8 SP lineage. These findings suggest that Runx3d transcription can be activated regardless of MHC restriction but is normally blocked by ThPOK in a CD4 + lineage-specific way. Analysis of regulation of the Runx3 distal promoter may clarify the potential cross-regulation between these two transcription factors. In mice lacking both ThPOK and Runx complexes, lineage redirection of MHC class II-restricted CD4 SP cells no longer occurred, which suggests that the CD4 + lineage can be specified even in the absence of ThPOK. Consistent with that interpretation, in preliminary studies we found that CD40L (CD154), which is expressed specifically in cells of the helper T cell lineage, was upregulated in CD4 + CD8 -T cells lacking both ThPOK and CBFb. This result seems at first to be inconsistent with those of previous studies of lineage regulation by ThPOK and Runx. For example, derepression of ThPOK in the absence of Runx complexes in DP cells results in diversion of MHC class I-restricted cells to the CD4 + lineage 14 . However, this effect was not demonstrated to be dependent on ThPOK. Similar lineage diversion noted after targeted deletion of the ThPOK silencer may have resulted in higherthan-normal amounts of ThPOK in MHC class I-selected cells; this higher ThPOK expression may thus have effectively represented a 'phenocopy' of forced ThPOK expression in transgenic mice and may have bypassed the transcriptional mechanisms that normally precede ThPOK upregulation during CD4 + lineage specification 14 .
Our results therefore suggest that signals initiated in DP thymocytes after the interaction of TCRs with peptide-loaded MHC class II molecules specify differentiation to the CD4 + lineage before the activity of ThPOK, which is expressed in this lineage after release of its silencing and, possibly, activation of lineage-restricted positive regulatory elements 14 . The signals and factors involved in specification of the CD4 + lineage and in the induction of ThPOK remain to be defined. GATA-3, another transcription factor known to be required for the differentiation of CD4 + lineage cells, is upregulated earlier than ThPOK is at the CD69 + TCR lo DP stage 29 . In the absence of GATA-3, MHC class II-selected thymocytes are arrested at the CD4 + CD8 lo stage 30 . GATA-3 or other unknown CD4-specification factors may be required for ThPOK upregulation, although a GATA-3 consensus binding sequence in the ThPOK silencer seems to be dispensable 15 .
The findings noted above are consistent with the idea that there is reciprocal regulation of ThPOK and Runx complexes. Runx1 and Runx3 are required for ThPOK silencing in DP cells, although their function in ThPOK regulation after positive selection remains unclear. Specific expression of Runx3 in the CD8 SP lineage raises the possibility that ThPOK silencing is maintained by Runx3 in MHC class I-restricted thymocytes and that ThPOK silencing is 'released' in MHC class II-selected thymocytes that do not express Runx3. However, as ThPOK upregulation in MHC class II-selected thymocytes occurs earlier than Runx3 upregulation occurs in MHC class Iselected thymocytes, it is unlikely that Runx3 determines lineagespecific ThPOK expression. Alternatively, it is possible that Runx1 may modulate ThPOK silencer activity after positive selection signals by acting either alone or together with other CD4 SP-specifying factors, such as GATA-3. Indeed it has been shown that Runx and GATA factors potentially interact with each other and synergistically regulate blood cell lineage 'decisions' in drosophila 31, 32 .
The functions of ThPOK and Runx factors in the helper T cellversus-cytotoxic T cell lineage 'decision' seem to be asymmetric. Whereas ThPOK represses Runx3 expression after positive selection, the Runx proteins do not seem to prevent ThPOK expression except at the DP stage. In contrast to the effect of forced expression of ThPOK, transgenic overexpression of Runx proteins fails to redirect MHC class II-specific cells to the CD8 + lineage. Therefore, after induction of ThPOK in thymocytes of the CD4 + lineage, its expression seems to become resistant to Runx-mediated repression. This may be due to epigenetic changes or to active inhibition of the repressive effect of Runx complexes, which have been reported to remain associated with the ThPOK silencer even in cells of the CD4 + lineage 14 .
ThPOK probably functions not only to repress Runx3 expression but also to repress genes encoding other factors involved in cytotoxiclineage commitment or to insulate genes involved in CD4 + lineage commitment from the effects of Runx expression. Thus, in the absence of ThPOK, not only Runx proteins but also other ThPOK target genes are probably involved in the diversion to the CD8 + lineage. After intrathymic differentiation, ThPOK and Runx3 protein can be expressed together in activated peripheral CD4 + T cells in T H 1polarizing conditions 12, 13 (data not shown). The mechanism that permits Runx3 expression in mature cells in the presence of ThPOK is unknown, but it may involve a dominant function for the transcription factor T-bet, which is required for Runx3 expression in T H 1 cells 13 . Effector helper T cell functions may depend on the expression of both ThPOK and Runx3.
The 'kinetic signaling' model of the CD4-versus-CD8 lineage 'choice' 33, 34 proposes that during the CD4 + CD8 lo stage after positive selection, extended signaling due to the interaction of CD4 with MHC class II results in helper-lineage specification. Our results are potentially consistent with that model and are the first to our knowledge to demonstrate that the CD4 + CD8 lo thymocyte subpopulation is heterogeneous in terms of ThPOK expression. It is thus possible that only those cells with prolonged signaling upregulate ThPOK. These may also be cells that 'preferentially' upregulate GATA-3 in response to MHC class II (ref. 29) .
In summary, we have provided genetic evidence that suggests that ThPOK may not be essential for specification of the CD4 SP lineage, whereas Runx complexes are required for lineage redirection in the absence of ThPOK. ThPOK is essential in preventing commitment to the cytotoxic T lymphocyte lineage after MHC class II-restricted selection, at least in part by inhibiting upregulation of Runx3 from the distal promoter. Further studies are needed to identify factors necessary for CD4 + lineage specification before ThPOK induction, to determine if there is a basal differentiation state after positive selection by either MHC class I or MHC class II, and to elucidate the generegulatory network governing thymocyte lineage diversification.
METHODS
Mice. Mice with conditional knockout of Cbfb, Runx3 and Runx1 have been described 8, 12 . B2m -/mice 35 , H2-Ab1 -/mice 36 and Cd4-Cre-and Lck-Cretransgenic mice 37 were from Taconic Farms, and EIIa-Cre-transgenic mice 38 were from the Jackson Laboratory. For targeted insertion of sequence encoding YFP into the Runx3 locus, genomic fragments for homologous arms were amplified by PCR from a bacterial artificial chromosome clone (RP24-309N18) encompassing the Runx3 locus. A targeting vector was constructed such that a 46-nucleotide sequence encoding Runx3, starting with an initiating codon from the distal promoter transcript, was replaced with sequence encoding YFP. The NotI-linearized targeting vector was transfected by electroporation into embryonic stem cells, and colonies doubly resistant for the aminoglycoside G418 and gancyclovir were screened by PCR for homologous recombination at the 3¢ end. Positive clones were confirmed by Southern blot analysis with BamHI digestion. Genomic fragments encompassing the ThPOK locus were excised from a bacterial artificial chromosome clone (RP23-126P10) and were cloned into pBluescript. For targeted deletion or conditional targeting of ThPOK, a targeting vector was constructed to flank exons 2 and 3 (containing the entire coding sequence of ThPOK) with loxP sites. The neomycin-resistance cassette was inserted approximately 1.1 kilobases upstream of exon 2 in a forward orientation with an additional loxP site at its 5¢ end. A SacII-linearized targeting vector was transfected into embryonic stem cells by electroporation. Colonies doubly resistant for G418 and gancyclovir were screened by Southern blot analysis. For the generation of ThPOK F/+ mice, ThPOK FN/+ embryonic stem cells were transiently transfected with pMC-Cre to remove the neomycin-resistance gene. The ThPOKallele was obtained by crossing of ThPOK FN/+ mice with EIIa-Cretransgenic mice. All mice were maintained in specific pathogen-free conditions in the Skirball Institute Animal Facility. All experiments were done in accordance with a protocol approved by the Institutional Animal Care and Use Committee of the New York University School of Medicine.
Flow cytometry. Monoclonal antibodies to CD4 (RM4-5), CD8a (53-6.7), TCRb (H57-597), HSA (M1/69), CD69 (H1.2F3) and CD103 (2E7) were from eBioscience; anti-CD154 (MR1), anti-IL-4 (11B11) and anti-IFN-g (XMG1.2) were from BD Biosciences. Single-cell suspensions were stained with antibodies and the DNA-intercalating dye DAPI (4,6-diamidino-2-phenylindole) and were analyzed with an LSRII (BD Biosciences) equipped with 355-nm, 405-nm, 488-nm and 633-nm lasers. 510/20, 545/35, 495LP and 525LP filters were used to separate GFP and YFP signals. Data were analyzed with FlowJo software (TreeStar). Cells were sorted with a FACSAria (BD Biosciences). The purity of sorted samples was over 99%.
Real time PCR for gene-expression analysis. Total RNA was prepared from sorted thymocytes or lymphocytes with TRIzol (Invitrogen), and cDNA was synthesized with SuperScript reverse transcriptase (Invitrogen). Real-time PCR analysis was done as described 10 . Primers and Taqman probes for Gata3 and ThPOK have been described 6, 39 (other primer sequences, Supplementary Table 1 online). Gene expression was assessed in three independent samples and statistical differences were analyzed with a twotailed t-test with unequal variance assumption. P values below 0.05 were considered significant.
Immunoblot analysis. Cells purified by flow cytometry were washed once with PBS and were lysed in a buffer of 150 mM NaCl, 2 mM EDTA, 20 mM Tris-HCl, pH 7.5, 10% (vol/vol) glycerol and 1% (vol/vol) Nonidet-P40. Lysates were cleared by centrifugation, were denatured in 1Â Laemmli buffer and were separated by SDS-PAGE. Antibody to the carboxyl terminus of Runx1 and Runx3 has been described 10 . Anti-ThPOK was generated by immunization of rabbits with a fusion protein of recombinant glutathione S-transferase and amino acids 423-543 of ThPOK. Crude serum was used for immunoblot analysis. Antibody to HMG1 (high-mobility group 1 protein; 556528; BD Biosciences) was used to estimate loading. Uncropped gel images are in Supplementary Figure 7 online.
T cell stimulation and intracellular staining. Purified naive CD4 + CD8 -CD25 -CD62L + CD44 lo T cells were stimulated for 3 d with plate-bound anti-CD3 (1 mg/ml; 145-2C11) and anti-CD28 (5 mg/ml; 37.51) in the presence of recombinant mouse IL-2 (20 U/ml) and in the absence of IL-12. Cells were restimulated for 4 h with phorbol 12-myristate 13-acetate and ionomycin in the presence of GolgiPlug (BD Biosciences), were fixed with 2% (wt/vol) paraformaldehyde, were made permeable with 0.03% (wt/vol) saponin and were stained intracellularly for IFN-g and IL-4 in the presence of 0.3% (wt/vol) saponin.
Accession codes. UCSD-Nature Signaling Gateway (http://www.signaling-gate way.org): A000523 and A000524.
Note: Supplementary information is available on the Nature Immunology website.
